Award

Amyloid deposition and preexisting vulnerable carotid plaque features predicting cognitive improvement after surgery

Description: Cardiovascular disease and stroke are leading causes of morbidity and mortality in the United States, with total costs exceeding $300 billion/year. Approximately 25% of the nearly 700,000 acute ischemic strokes/year are attributed to carotid plaque. In the last few years, research by our institution and others has found that MRI-detected carotid intraplaque hemorrhage (IPH) is a better marker of unstable plaque and ischemic stroke risk compared to stenosis. Atherosclerosis is also thought to be an important factor in cognitive decline. One hypothesis is that hypoperfusion and impaired A&#946; clearance across the blood-brain barrier may contribute to A&#946; accumulation in blood vessel walls and brain parenchyma. In a small study on patients with >60% carotid stenosis, brain amyloid deposition was asymmetrically increased on the side of carotid stenosis and thought to be secondary to cerebral hypoperfusion. However, the majority of these patients had <90% stenosis, and cerebral blood flow is not reduced until stenosis exceeds 90%. Because carotid IPH is a better marker of vulnerable carotid plaque, we hypothesize that carotid IPH leads to increased downstream brain inflammation and amyloid deposition, secondary to microembolic events as opposed to decreased perfusion. Furthermore, studies have found that carotid revascularization restores cognition scores in nearly 50% of patients, with benefits primarily seen with endarterectomy as opposed to stenting. This research argues that potential restoration of flow is not fully protective from carotid plaque unless the inciting vessel wall inflammation is removed. We propose a clinical study on patients undergoing carotid surgery (endarterectomy) to determine if carotid IPH is associated with (1) vessel wall inflammation as detected by macrophage expression of bAPP in carotid plaque, (2) downstream brain inflammation detected by [18F]flutemetamol-PET, and (3) a increased cognitive benefit from surgery as compared to measures of stenosis. By uncovering the links between inflamed carotid IPH and brain inflammation, we believe this project has important implications for translational science and may provide important imaging targets to monitor treatment efficacy and discover new therapies. We also believe this project will directly and immediately impact patients with carotid disease, by determining potential cognitive benefit from carotid surgery depending on symptomatic status, stenosis and carotid IPH.
Amount: $226,700
Funding type: fellowship
Funder scheme: Scientist Development Grant
Start date: 2017-01-01
End date: 2019-12-31
Investigator: Joseph McNally (lead)
Institutions: University of Utah, The University of Utah
Field: Medicine
Funded outputs count: 12
Funder award ID: 17SDG33460420
OpenAlex ID: G3512697373
2022 · S. Culleton, H. Baradaran, et al. · American Journal of Neuroradiology · 2
2022 · Hediyeh Baradaran, Sinead Culleton, et al. · Neuroradiology · 12
2021 · Justin Costello, Matthew D. Alexander, et al. · Radiographics · 5
2021 · Hediyeh Baradaran, Alen Delic, et al. · Dementia and Geriatric Cognitive Disorders Extra · 3
2021 · J.S. McNally, A. Sakata, et al. · American Journal of Neuroradiology · 19
2021 · Hediyeh Baradaran, Laura B. Eisenmenger, et al. · Journal of the American Heart Association · 45
2020 · Hediyeh Baradaran, Tyrel Foster, et al. · Neuroradiology · 16
2020 · John Michael S. Sanchez, J. Scott McNally, et al. · Frontiers in Neurology · 15
2019 · J. Scott McNally, Jared A. Jaffey, et al. · Frontiers in Veterinary Science · 6